The campaign focused on reframing obesity as a chronic disease through media, social platforms and public messaging, without directly naming the drug. However, regulators flagged concerns that it could indirectly promote the medicine and sought clarification from the company.
Eli Lilly has paused an obesity awareness campaign in India in response to a regulatory notice about the rules on advertising prescription medicines, Reuters reports. In March, Indias Central Drugs Standard Control Organization (CDSCO)...
Eli Lilly launched their obesity awareness campaign in India in the middle of 2025 following their introduction of GLP-1 treatment Mounjaro for obesity and diabetes.
If awareness campaigns (like National Childhood Obesity Awareness Month in September) are evaluated, theyre usually evaluated by asking: did this succeed in raising awareness? But we should be asking: is this actually helping?
Theyre made by the same companies that make Ozempic-style weight-loss drugs. But you wont see the drug names mentioned that would be illegal in Australia. The companies say they're simply raising awareness about obesity as a chronic disease.
As we can see from the illustration, Grapes And Dog Obesity Awareness Campaigns has many fascinating aspects to explore.
To evaluate how weight changed based on obesity awareness, researchers examined self-reported perceptions of participants weight right as they reached adolescence.According to The Week, this study may mean reevaluating campaigns like First Lady Michelle Obamas Lets Move!
